Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ligand Pharmaceuticals Inc (NASDAQ:LGND)

Tuesday’s trading has closed, but LGND is being traded in the after-hours session. After-Hours quote »
88.48
Delayed Data
As of 3:59pm ET
 -3.46 / -3.76%
Today’s Change
41.99
Today|||52-Week Range
112.40
+66.28%
Year-to-Date

Today’s Trading

Previous close91.94
Today’s open89.79
Day’s range87.78 - 91.39
Volume412,061
Average volume (3 months)417,822
Market cap$1.8B
Dividend yield--
Data as of 3:59pm ET, 09/01/2015

Growth & Valuation

Earnings growth (last year)+31.55%
Earnings growth (this year)+131.80%
Earnings growth (next 5 years)+40.00%
Revenue growth (last year)+31.78%
P/E ratio57.0
Price/Sales17.67
Price/Book68.38

Competitors

 Today’s
change
Today’s
% change
PRTAProthena Corporation...-3.15-5.48%
USNAUSANA Health Science...-5.00-3.41%
LCILannett Company Inc-0.66-1.38%
FOLDAmicus Therapeutics ...-0.10-0.70%
Data as of 4:02pm ET, 09/01/2015

Financials

Next reporting dateNovember 10, 2015
EPS forecast (this quarter)$0.42
Annual revenue (last year)$64.5M
Annual profit (last year)$12.0M
Net profit margin18.63%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John L. Higgins
President &
Chief Operating Officer
Matthew W. Foehr
Corporate headquarters
La Jolla, California

Forecasts

Partner Offers